We are monitoring the impact of COVID-19 on APAC Viscosupplementation Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11528
Share on
Share on

APAC Viscosupplementation Market Research Report - Segmented By Product Type, End-User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Share, Trends & Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11528
Pages: 100

APAC Viscosupplementation Market Size (2021 to 2026)

The size of the APAC Viscosupplementation Market was valued at USD 918 million in 2020 and is forecasted to grow at a CAGR of 10.04% between 2021 to 2026.

The prevalence of lifestyle-related disorders and advances in the production of hyaluronic acid-based therapies are expected to drive the viscosupplementation market in the APAC region. Also, the growing demand for non-surgical treatments for osteoarthritis and advancements in the development of hyaluronic are to increase the market growth.  Intra-articular injections of hyaluronic acid have proven to be one of the more common treatments for symptomatic knee osteoarthritis, improving market growth. In addition, the favorable reimbursement programs in the APAC region are likely to encourage regional market growth. Muscles are lubricated as HA is injected into them, enabling them to glide smoothly alongside one another. Arthritic joints can move more easily and safely when they are supplemented with viscosupplementation. When other nonsurgical care options have failed to yield acceptable outcomes, it is often recommended.

Advancements in product pipeline R&D in developing countries such as China and India create new opportunities for the viscosupplementation market to grow in Asian countries. Viscosupplements available in the market have shown clinical efficacy and are proven to be the most effective treatment for knee osteoarthritis. Outpatient facilities are gaining prominence in Asian countries because they provide Operational and economic efficiencies. They are making it easier for patients to get in; pricing is quite fair, there will be more chances for physicians to participate; as a result of all of the above considerations, the studied market is expected to develop in the future.

Lack of inefficiency and safety for the product is one of the major concerns for the market growth. Also, the high price of hyaluronic acid treatment is expected to hinder the APAC viscosupplementation market growth. 

Impact of COVID-19 on APAC Viscosupplementation Market:

COVID-19 was identified in the Asian country, China, and spread to all Asian countries and led to the lockdown in the region. The sudden emergence of the pandemic has negatively impacted the economy and operations in ways that have never been seen before. Uncertainty over developing and commercializing viable care solutions for the treatment cannot be ruled out. The governments across the APAC are engaging healthcare workers to cope up with the COVID-19 crisis. 

Moreover, with developing economies such as India and China recovering from the COVID-19 pandemic, the viscosupplementation market is anticipated to gain momentum by 2021.

This market research report on the APAC viscosupplementation market has been segmented and sub-segmented into the following categories.

By Product:

  • Single Injection
  • Three Injection
  • Five Injection

By End-Use:

  • Hospitals
  • Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia-pacific viscosupplementation market is anticipated to register healthy CAGR during the forecast period. Factors such as improving healthcare infrastructure in this region, furthermore, the low cost of manufacturing in China and India has led to an increase in production facilities, drawing pharmaceutical and biotechnological giants from all over the world to the Asia-Pacific region. China, India, Japan, and Australia are the major growth contributors in the region.

The Chinese viscosupplementation market is forecasted to account major chunk of the APAC regional market share during the forecast period. The growing number of rheumatoid arthritis diseases, the growing demand for non-surgical treatments for osteoarthritis, and the proliferation of lifestyle-induced disorders drive the market growth for viscosupplementation in the country.

The Indian viscosupplementation market is one of the fastest-growing regions in the APAC regional market. Over the past years, with the move to value-based care, hospitals and healthcare systems face extreme competition from outpatient service sites, particularly those that offer physician office-based procedures and ambulatory surgery in the Indian market. However, increasing awareness about the new drugs and devices for the treatment, growing geriatric population, and demand for minimally invasive surgical operations drive the growth of the market.

KEY MARKET PARTICIPANTS:

Noteworthy companies dominating the APAC viscosupplementation market analyzed in this report are Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Anika Therapeutics Inc., Fidia Farmaceutici S.p.A., Ferring B.V., Seikagaku Corporation, Chungai Pharmaceutical Co., Ltd., OrthogenRx Inc., and Mylan N.V.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Single Injection
      2. Three Injection
      3. Five Injection
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By End-User
      1. Hospitals
      2. Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Sanofi S.A.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Zimmer Biomet Holdings Inc.
    3. Bioventus LLC
    4. Anika Therapeutics Inc.
    5. Fidia Farmaceutici S.p.A.
    6. Ferring B.V.
    7. Seikagaku Corporation
    8. Chungai Pharmaceutical Co., Ltd.
    9. OrthogenRx Inc.
    10. Mylan N.V
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  2. Asia Pacific Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  6. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  8. Japan Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  9. Japan Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  10. China Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  11. China Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  12. India Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  13. India Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  14. Australia Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  15. Australia Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  16. South Korea Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  17. South Korea Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample